Size-dependent nanographene oxide as a platform for efficient carboplatin release.

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Graphite-derived nanographene oxides (NGO) are promising nanomaterials.
• Controlling NGO size is crucial for biomedical applications.
• Functionalization enhances nanomaterial stability and dispersibility in physiological environments.

Purpose of the Study:

• To synthesize size-controlled nanographene oxides (NGOs).
• To functionalize NGOs with polyamidoamide (PAMAM) for improved nanocarrier properties.
• To evaluate the efficacy and safety of carboplatin-loaded NGO-PAMAM carriers for cancer therapy.

Main Methods:

• Chemical exfoliation of graphite to produce NGOs.
• Intense sonication and sucrose density gradient centrifugation for size separation (100 nm, 200 nm, 300 nm).
• Functionalization of NGOs with zero-generation PAMAM.
• In vitro cell viability assays using HeLa cancer cells and human mesenchymal stem cells (hMSCs).

Main Results:

• Pristine 100 nm NGOs exhibited minimal cytotoxicity to HeLa cells and hMSCs.
• NGOs larger than 100 nm showed dose-dependent cytotoxicity.
• PAMAM-functionalized NGO carriers effectively delivered carboplatin, enhancing anticancer efficacy.
• Carboplatin-loaded NGO-PAMAM carriers demonstrated no significant cytotoxicity to hMSCs.

Conclusions:

• Size-controlled NGO-PAMAM nanocarriers offer a safe and effective platform for targeted drug delivery.
• The NGO-PAMAM system enhances carboplatin's therapeutic index by increasing cancer cell killing while sparing healthy cells.
• This nanocarrier platform holds potential for developing advanced cancer therapeutics.